dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Pozo-Rosich, Patricia |
dc.contributor.author | Gil-Gouveia, Raquel |
dc.contributor.author | Donnet, Anne |
dc.contributor.author | Poole, Anne-Christine |
dc.contributor.author | Gendolla, Astrid |
dc.contributor.author | Afridi, Shazia |
dc.date.accessioned | 2022-01-31T10:55:00Z |
dc.date.available | 2022-01-31T10:55:00Z |
dc.date.issued | 2021-11 |
dc.identifier.citation | Pozo-Rosich P, Gil-Gouveia R, Donnet A, Poole AC, Gendolla A, Afridi S, et al. Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment: my-LIFE European Delphi survey. Eur J Pain. 2021 Nov;25(10):2177–89. |
dc.identifier.issn | 1532-2149 |
dc.identifier.uri | https://hdl.handle.net/11351/6935 |
dc.description | Mètode Delphi; Eficàcia dels fàrmacs preventius de la migranya |
dc.description.sponsorship | Novartis Pharma AG financially supported the development of this project, the medical writing assistance and the page processing charges for this article. The authors have received no payment to write this article. |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | European Journal of Pain;25(10) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Migranya - Prevenció |
dc.subject | Qüestionaris |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Migraine Disorders |
dc.subject.mesh | /prevention & control |
dc.subject.mesh | Delphi Technique |
dc.subject.mesh | Treatment Outcome |
dc.title | Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment: my-LIFE European Delphi survey |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/ejp.1831 |
dc.subject.decs | trastornos migrañosos |
dc.subject.decs | /prevención & control |
dc.subject.decs | técnica Delfos |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1002/ejp.1831 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pozo-Rosich P] Unitat de Cefalea, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Gil-Gouveia R] Headache Center, Neurology Department, Hospital da Luz, Lisboa, Portugal. [Donnet A] Pain Department, Timone Hospital, Marseille, France. [Poole AC] Private Practice: Oslo Headache Centre, Oslo, Norway. [Gendolla A] Private Practice: Essen, Germany. [Afridi S] Headache Service, Department of Neurology, Guy’s and St Thomas’ NHS Trust, London, UK |
dc.identifier.pmid | 34173301 |
dc.identifier.wos | 000672992300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |